138
Views
11
CrossRef citations to date
0
Altmetric
Original Research

Glucocorticoid Receptor α Mediates Roflumilast’s Ability to Restore Dexamethasone Sensitivity in COPD

, , &
Pages 125-134 | Published online: 14 Jan 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Maria Gabriella Matera, Josuel Ora, Francesco Cavalli, Paola Rogliani & Mario Cazzola. (2021) New Avenues for Phosphodiesterase Inhibitors in Asthma. Journal of Experimental Pharmacology 13, pages 291-302.
Read now

Articles from other publishers (10)

Huanming Huang, Wenqing Wang, Yu Cui, Cai-Xia Hu & Ming Du. (2023) Correlation between nuclear expression of heat shock protein 90 in dermis and glucocorticoid resistance in bullous dermatosis. Steroids 194, pages 109223.
Crossref
Pengcheng Zhou, Jianli Ma, Wei Yu, Keling Chen, Wensheng Zhang & Jiang Zhou. (2023) Tiao-Bu-Fei-Shen Formula Improves Glucocorticoid Resistance of Chronic Obstructive Pulmonary Disease via Downregulating the PI3K-Akt Signaling Pathway and Promoting GRα Expression. Evidence-Based Complementary and Alternative Medicine 2023, pages 1-17.
Crossref
Huanming Huang & Wenqing Wang. (2022) Molecular mechanisms of glucocorticoid resistance. European Journal of Clinical Investigation 53:2.
Crossref
Ravi Mishra, Zia Hashim, Mansi Gupta, Rachna Chaturvedi, Harshit Singh, Alok Nath, DurgaPrasanna Misra, Ajmal Khan, MohitKumar Rai, Shivani Srivastava, Saurabh Chaturvedi & Vikas Agarwal. (2022) Histone deacetylase-2 inducer like theophylline has a potential to improve glucocorticoid responsiveness in severe uncontrolled asthma by reducing P-glycoprotein/MRP-1. Indian Journal of Rheumatology 17:1, pages 47.
Crossref
Brandon W. Lewis, Maria L. Ford, Lynette K. Rogers & Rodney D. BrittJr.Jr.. (2021) Oxidative Stress Promotes Corticosteroid Insensitivity in Asthma and COPD. Antioxidants 10:9, pages 1335.
Crossref
Mark J. Turner, Nurlan Dauletbaev, Larry C. Lands & John W. Hanrahan. (2020) The Phosphodiesterase Inhibitor Ensifentrine Reduces Production of Proinflammatory Mediators in Well Differentiated Bronchial Epithelial Cells by Inhibiting PDE4. Journal of Pharmacology and Experimental Therapeutics 375:3, pages 414-429.
Crossref
Manar Mohammed El Tabaa & Maram Mohammed El Tabaa. (2020) New putative insights into neprilysin (NEP)-dependent pharmacotherapeutic role of roflumilast in treating COVID-19. European Journal of Pharmacology 889, pages 173615.
Crossref
Shradha Bodkhe, Mayuri Nikam, Atul P. Sherje, Tabassum Khan, Vasanti Suvarna & Kavit Patel. (2020) Current insights on clinical efficacy of roflumilast for treatment of COPD, asthma and ACOS. International Immunopharmacology 88, pages 106906.
Crossref
Aravind T. Reddy, Sowmya P. Lakshmi, E. Maruthi Prasad, N.Ch. Varadacharyulu & Lakshmi Devi Kodidhela. (2020) Epigallocatechin gallate suppresses inflammation in human coronary artery endothelial cells by inhibiting NF-κB. Life Sciences 258, pages 118136.
Crossref
Andrew Higham, Tom ScottJian LiRosemary GaskellAisha Baba DikwaRajesh ShahM. Angeles Montero-FernandezSimon LeaDave Singh. (2020) Effects of corticosteroids on COPD lung macrophage phenotype and function. Clinical Science 134:7, pages 751-763.
Crossref